Cost Quietly Remains The 800-Pound Gorilla In The CER Room
Executive Summary
In the run-up to passage of the Patient Protection and Affordable Care Act, there was much debate on the subject of cost effectiveness in the context of comparative effectiveness research, with legislators carefully wording CER provisions to keep cost effectiveness at bay
You may also be interested in...
Employers Eye CER To Improve Employee Health, Lower Costs – NPC Survey
Large employers and those companies that self-insure are expecting that comparative effectiveness research will lead to better employee health and help companies achieve their cost-management goals, according to the results of a survey released June 21 by the National Pharmaceutical Council.
Employers Eye CER To Improve Employee Health, Lower Costs – NPC Survey
Large employers and those companies that self-insure are expecting that comparative effectiveness research will lead to better employee health and help companies achieve their cost-management goals, according to the results of a survey released June 21 by the National Pharmaceutical Council.
CER Has Been A Part Of CMS Coverage Decisions In Recent Years – Avalere
During the health care reform debate, much concern was expressed that results of comparative effectiveness research from the Patient-Centered Outcomes Research Institute could play a key role in Medicare coverage decisions. But CER has already been considered in making Medicare coverage decisions for years, recent Avalere Health analysis of national coverage determinations issued by CMS points out.